Research

Recognizing the need for concerted efforts to build infrastructures in the Developing World capable of providing research capacity concomitantly with service,

the Duke International Health Program has responded to numerous Requests for Applications from the NIH and the CDC to accomplish this in Africa. These applications include the AIDS International Training and Research Program (AITRP/NIH), the International AIDS Clinical Trials Group (IACTG/NIH), the Doris Duke Foundation, the Potential Extramural Research Trials (PERT/CDC), the Comprehensive International Program for Research on AIDS (CIPRANIH), the Program Project on Development of Vaccines for HIV, TB and Malaria (PO1/NIH) and Industry Awards from Glaxo-Smith/Kline and Abbott.  While final decisions have not been made on all of these, the prospects for substantial financial support are excellent. Already, funds were awarded under the CIPRA proposal to proceed with planning to develop a "HIV Clinical Trials Planning Site in Northern Tanzania" in collaboration with our partner at the Kilimanjaro Christian Medical Center (KCMC). The first planning meeting was held in Tanzania in November, 2002 and was attended by representatives from the Tanzanian Ministry of Health, Regional Health Departments and National AIDS Control Program, the World Health Organization, Harvard University, the Centers for Disease Control and senior personnel from KCMC and Duke. In addition, Dr Nathan Thielman is a recent recipient of a Fulbright Fellowships and Dr John Bartlett is the probable recipient of a Fogarty Center-sponsored FIRCA Award. These activities reflect the extraordinary commitment of the faculty to the Duke International Program and, as a result, a very high likelihood of success.